Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
eNq1mFFv2jAQx9/5FFHeSUg7oJ0C1cZgQ2pVRos27aUyyQFmwU7PNtB9+jmEbnRy1NXgx/ic/519559Pjq+2q8xbAwrKWcePgobvAUt4Stm840/uB/UL/6pbi5dkTQ6mtYNGEJ35XpIRITp+YQ2mQJgIvt9cfwL9P6DfrXkxny4hkS/mKUmz4AsRixuSF3O8eM1p6q1ALnja8XMld6NeLCTqKLobjj9FThKIw/3IoXX58O5wPA4Lsf9QVQLwmrC5URSYlWaiEIHJHpEw5/hUEe+5lTYVYxBcYQIjIhcj5GuaQmp0MSOZACsns016B7jOQBZOjOLhMlkJK3GyJNsxPA7NQX/Q1p7cynqjHrVbrYuzRqPdvGxFVq7wYKvMWdCLCJOH6Lx52T5vhMC0srbo5FkmZ8RRksxRWqjovawsR34QHl9Nf0pFnpGnYCly260iSLQZUJ9/dwspVnCPmkiZ3rN/9JnKsvCNUU/2vHAUcYGjHldMVmBjMLbdiB5nErbVGbUjndzua5GCOJ3sL87MlB+paUYTW6Zp6igQcjIeViPtpDT4SARM0B0OvlGW8o04PWYO0+oo+nxHSqNojmn0cHZ50YqaTetT9EPXUMUd01fIcwg1gKg4hitDNuPHEkWXpVnquShPV4+7VocnJIOKZqduSRddiM+9mbNSd3eMSoNR9HP/3rY+virAp7vdp1Gapp0/mbVDrwue62qsDPzttV0ecSdtsEIzOhZS5uJ9GG42m2BBRF0QvUvBDE/P9oP71F0X7uTSLpuYko+OQp+WF9/bUmR71F671o9tVff/71tiow+JCo7IRUllZ+wc9k+P4799qrOwRy/w4c7NrqckknLmqtVRU6PicReAzisboAbE7WxGK15FKusyDssXmW4tDovXmG7tN89p5uQ=
jeNPKAf5JFKfbEQm
Listen
